Filter Your Search

Clinical Trial Search

Keyword

Principal Investigator

Condition/Disease

For Healthcare Professionals

At Henry Ford Health System we serve a triple mission of Clinical Care, Research and Education. It is this triple mission that drives how we care for our patients, how we interact with referring physicians, how we work to innovate healthcare and how we train future physicians.

Learn More

Clinical Trials Search Results

PTC-299-HEM-001-LEU: Phase 1b Study of PTC299 in Relapsed/Refractory Acute Leukemias

Principal Investigator:Ahmad H Mattour, MD

Status: Accepting Participants

Contact Phone: (888) 734-5322

Contact Email: [email protected]

LOXO-RET-17001: A Phase 1/2 Study of Oral LOXO-292 in Patients with Advanced Solid Tumors, Including RET Fusion-Positive Solid Tumors, Medullary Thyroid Cancer, and Other Tumors with RET Activation (LIBRETTO-001)

Principal Investigator:Ding Wang, MD

Status: Accepting Participants

Contact Phone: 1-888-734-5322

Contact Email: [email protected]

GBM 001: An Open-Label, Multi-Center Trial of INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination with REGN2810 in Subjects with Newly-Diagnosed Glioblastoma

Principal Investigator:Tobias Walbert, MD

Status: Accepting Participants

Contact Phone: (313) 916-3731

Contact Email: [email protected]

MK4830-001: A Phase 1 Open Label, Multi-Arm, Multicenter Study of MK-4830 as Monotherapy and in Combination With Pembrolizumab for Participants With Advanced Solid Tumors

Principal Investigator:Ding Wang, MD

Status: Open

Contact Phone: (313) 916-7450

Contact Email: [email protected]

RPC-1063-MS-001: A Multicenter, Longitudinal, Open-Label, Single-Arm Study Describing Cognitive Processing Speed Changes in Relapsing Multiple Sclerosis Subjects Treated with Ozanimod

Principal Investigator:Anza B Memon, MD

Status: Accepting Participants

Contact Phone: 313-916-1482

Contact Email: [email protected]

MS200527-0018 A Phase II, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study Examining the Safety and Efficacy of M2951 in Subjects with Systemic Lupus Erythematosus (SLE)

Principal Investigator:Kathleen M Maksimowicz-Mckinnon, DO

Status: Accepting Participants

Contact Phone: (313) 916-9328

Contact Email: [email protected]

MS100015-0019: Open-label, Phase I, Dose Escalation Trial, investigating Methionine Aminopeptidase 2 Inhibitor M8891 in Subjects with Advanced Solid Tumors

Principal Investigator:Ding Wang, MD

Status: Accepting Participants

Contact Phone: (313)916-1784

Contact Email: [email protected]

Catalyst MSK 002: A Randomized, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of Amifampridine Phosphate in Patients with MuSK Antibody Positive Myasthenia Gravis, and a Sample of AChR Antibody Positive Myasthenia Gravis Patients

Principal Investigator:Kavita M Grover, MD

Status: Accepting Participants

Contact Phone: (313) 916-1364

Contact Email: [email protected]

P2B001-003, A Phase 3, Twelve-week, Multi-Center, Randomized, Double-Blind, active-controlled, Parallel Group Study to Determine the Safety, Tolerability, and Efficacy of P2B001 Compared to its Individual Components in Subjects with Early Parkinson's Disease

Principal Investigator:Peter A Le Witt, MD

Status: Accepting Participants

Contact Phone: (248) 661-6540

Contact Email: [email protected]

MS200527-0082: A Phase III, Multicenter, Randomized, Parallel Group, Double Blind, Double Dummy, Active Controlled Study of Evobrutinib Compared With Teriflunomide, in Participants With Relapsing Multiple Sclerosis to Evaluate Efficacy and Safety

Principal Investigator:Mirela Cerghet, MD

Status: Accepting Participants

Contact Phone: 313-916-1482

Contact Email: [email protected]

Page 1 of 36 | Results 1 - 10 of 356

Browse Locations by Type Search All Locations

Frequently Searched ServicesSearch All Services

Browse Services by A-Z

Connect with Us

Resources

Research & Education

Clinical Trial Search

For Healthcare Professionals

Clinical Trials Search Results

PTC-299-HEM-001-LEU: Phase 1b Study of PTC299 in Relapsed/Refractory Acute Leukemias

LOXO-RET-17001: A Phase 1/2 Study of Oral LOXO-292 in Patients with Advanced Solid Tumors, Including RET Fusion-Positive Solid Tumors, Medullary Thyroid Cancer, and Other Tumors with RET Activation (LIBRETTO-001)

GBM 001: An Open-Label, Multi-Center Trial of INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination with REGN2810 in Subjects with Newly-Diagnosed Glioblastoma

MK4830-001: A Phase 1 Open Label, Multi-Arm, Multicenter Study of MK-4830 as Monotherapy and in Combination With Pembrolizumab for Participants With Advanced Solid Tumors

RPC-1063-MS-001: A Multicenter, Longitudinal, Open-Label, Single-Arm Study Describing Cognitive Processing Speed Changes in Relapsing Multiple Sclerosis Subjects Treated with Ozanimod

MS200527-0018 A Phase II, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study Examining the Safety and Efficacy of M2951 in Subjects with Systemic Lupus Erythematosus (SLE)

MS100015-0019: Open-label, Phase I, Dose Escalation Trial, investigating Methionine Aminopeptidase 2 Inhibitor M8891 in Subjects with Advanced Solid Tumors

Catalyst MSK 002: A Randomized, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of Amifampridine Phosphate in Patients with MuSK Antibody Positive Myasthenia Gravis, and a Sample of AChR Antibody Positive Myasthenia Gravis Patients

P2B001-003, A Phase 3, Twelve-week, Multi-Center, Randomized, Double-Blind, active-controlled, Parallel Group Study to Determine the Safety, Tolerability, and Efficacy of P2B001 Compared to its Individual Components in Subjects with Early Parkinson's Disease

MS200527-0082: A Phase III, Multicenter, Randomized, Parallel Group, Double Blind, Double Dummy, Active Controlled Study of Evobrutinib Compared With Teriflunomide, in Participants With Relapsing Multiple Sclerosis to Evaluate Efficacy and Safety

Browse Locations by Type Search All Locations

Frequently Searched ServicesSearch All Services

Browse Services by A-Z

Connect with Us

Resources

Research & Education

Clinical Trial Search

For Healthcare Professionals

Clinical Trials Search Results

Consent for Cookie Use